Hepatitis B Immune Globulin Market
1 Hepatitis B Immune Globulin Market Overview
1.1 Product Overview and Scope of Hepatitis B Immune Globulin
1.2 Hepatitis B Immune Globulin Segment by Type
1.2.1 Global Hepatitis B Immune Globulin Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Intravenous Injection
1.2.3 Intramuscular Injection
1.3 Hepatitis B Immune Globulin Segment by Application
1.3.1 Global Hepatitis B Immune Globulin Sales Comparison by Application: (2022-2028)
1.3.2 Liver Transplant Patients
1.3.3 Newborn Baby
1.3.4 Others
1.4 Global Hepatitis B Immune Globulin Market Size Estimates and Forecasts
1.4.1 Global Hepatitis B Immune Globulin Revenue 2017-2028
1.4.2 Global Hepatitis B Immune Globulin Sales 2017-2028
1.4.3 Hepatitis B Immune Globulin Market Size by Region: 2017 Versus 2021 Versus 2028
2 Hepatitis B Immune Globulin Market Competition by Manufacturers
2.1 Global Hepatitis B Immune Globulin Sales Market Share by Manufacturers (2017-2022)
2.2 Global Hepatitis B Immune Globulin Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Hepatitis B Immune Globulin Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Hepatitis B Immune Globulin Manufacturing Sites, Area Served, Product Type
2.5 Hepatitis B Immune Globulin Market Competitive Situation and Trends
2.5.1 Hepatitis B Immune Globulin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Hepatitis B Immune Globulin Players Market Share by Revenue
2.5.3 Global Hepatitis B Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatitis B Immune Globulin Retrospective Market Scenario by Region
3.1 Global Hepatitis B Immune Globulin Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Hepatitis B Immune Globulin Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Hepatitis B Immune Globulin Market Facts & Figures by Country
3.3.1 North America Hepatitis B Immune Globulin Sales by Country
3.3.2 North America Hepatitis B Immune Globulin Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Hepatitis B Immune Globulin Market Facts & Figures by Country
3.4.1 Europe Hepatitis B Immune Globulin Sales by Country
3.4.2 Europe Hepatitis B Immune Globulin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hepatitis B Immune Globulin Market Facts & Figures by Region
3.5.1 Asia Pacific Hepatitis B Immune Globulin Sales by Region
3.5.2 Asia Pacific Hepatitis B Immune Globulin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Hepatitis B Immune Globulin Market Facts & Figures by Country
3.6.1 Latin America Hepatitis B Immune Globulin Sales by Country
3.6.2 Latin America Hepatitis B Immune Globulin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Hepatitis B Immune Globulin Market Facts & Figures by Country
3.7.1 Middle East and Africa Hepatitis B Immune Globulin Sales by Country
3.7.2 Middle East and Africa Hepatitis B Immune Globulin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Hepatitis B Immune Globulin Historic Market Analysis by Type
4.1 Global Hepatitis B Immune Globulin Sales Market Share by Type (2017-2022)
4.2 Global Hepatitis B Immune Globulin Revenue Market Share by Type (2017-2022)
4.3 Global Hepatitis B Immune Globulin Price by Type (2017-2022)
5 Global Hepatitis B Immune Globulin Historic Market Analysis by Application
5.1 Global Hepatitis B Immune Globulin Sales Market Share by Application (2017-2022)
5.2 Global Hepatitis B Immune Globulin Revenue Market Share by Application (2017-2022)
5.3 Global Hepatitis B Immune Globulin Price by Application (2017-2022)
6 Key Companies Profiled
6.1 ADMA Biologics
6.1.1 ADMA Biologics Corporation Information
6.1.2 ADMA Biologics Description and Business Overview
6.1.3 ADMA Biologics Hepatitis B Immune Globulin Sales, Revenue and Gross Margin (2017-2022)
6.1.4 ADMA Biologics Hepatitis B Immune Globulin Product Portfolio
6.1.5 ADMA Biologics Recent Developments/Updates
6.2 Bio Products Laboratory
6.2.1 Bio Products Laboratory Corporation Information
6.2.2 Bio Products Laboratory Description and Business Overview
6.2.3 Bio Products Laboratory Hepatitis B Immune Globulin Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Bio Products Laboratory Hepatitis B Immune Globulin Product Portfolio
6.2.5 Bio Products Laboratory Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Hepatitis B Immune Globulin Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Grifols Hepatitis B Immune Globulin Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Biotest AG
6.4.1 Biotest AG Corporation Information
6.4.2 Biotest AG Description and Business Overview
6.4.3 Biotest AG Hepatitis B Immune Globulin Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Biotest AG Hepatitis B Immune Globulin Product Portfolio
6.4.5 Biotest AG Recent Developments/Updates
6.5 CSL Behring
6.5.1 CSL Behring Corporation Information
6.5.2 CSL Behring Description and Business Overview
6.5.3 CSL Behring Hepatitis B Immune Globulin Sales, Revenue and Gross Margin (2017-2022)
6.5.4 CSL Behring Hepatitis B Immune Globulin Product Portfolio
6.5.5 CSL Behring Recent Developments/Updates
6.6 FFF Enterprises
6.6.1 FFF Enterprises Corporation Information
6.6.2 FFF Enterprises Description and Business Overview
6.6.3 FFF Enterprises Hepatitis B Immune Globulin Sales, Revenue and Gross Margin (2017-2022)
6.6.4 FFF Enterprises Hepatitis B Immune Globulin Product Portfolio
6.6.5 FFF Enterprises Recent Developments/Updates
6.7 Cleveland Clinic
6.6.1 Cleveland Clinic Corporation Information
6.6.2 Cleveland Clinic Description and Business Overview
6.6.3 Cleveland Clinic Hepatitis B Immune Globulin Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Cleveland Clinic Hepatitis B Immune Globulin Product Portfolio
6.7.5 Cleveland Clinic Recent Developments/Updates
7 Hepatitis B Immune Globulin Manufacturing Cost Analysis
7.1 Hepatitis B Immune Globulin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hepatitis B Immune Globulin
7.4 Hepatitis B Immune Globulin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hepatitis B Immune Globulin Distributors List
8.3 Hepatitis B Immune Globulin Customers
9 Hepatitis B Immune Globulin Market Dynamics
9.1 Hepatitis B Immune Globulin Industry Trends
9.2 Hepatitis B Immune Globulin Market Drivers
9.3 Hepatitis B Immune Globulin Market Challenges
9.4 Hepatitis B Immune Globulin Market Restraints
10 Global Market Forecast
10.1 Hepatitis B Immune Globulin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hepatitis B Immune Globulin by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Hepatitis B Immune Globulin by Type (2023-2028)
10.2 Hepatitis B Immune Globulin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hepatitis B Immune Globulin by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Hepatitis B Immune Globulin by Application (2023-2028)
10.3 Hepatitis B Immune Globulin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hepatitis B Immune Globulin by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Hepatitis B Immune Globulin by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Hepatitis B Immune Globulin Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Hepatitis B Immune Globulin Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Hepatitis B Immune Globulin Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Hepatitis B Immune Globulin Market Competitive Situation by Manufacturers in 2021
Table 5. Global Hepatitis B Immune Globulin Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Hepatitis B Immune Globulin Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Hepatitis B Immune Globulin Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Hepatitis B Immune Globulin Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Hepatitis B Immune Globulin Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Hepatitis B Immune Globulin Manufacturing Sites and Area Served
Table 11. Manufacturers Hepatitis B Immune Globulin Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hepatitis B Immune Globulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Immune Globulin as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Hepatitis B Immune Globulin Sales by Region (2017-2022) & (K Units)
Table 16. Global Hepatitis B Immune Globulin Sales Market Share by Region (2017-2022)
Table 17. Global Hepatitis B Immune Globulin Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Hepatitis B Immune Globulin Revenue Market Share by Region (2017-2022)
Table 19. North America Hepatitis B Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 20. North America Hepatitis B Immune Globulin Sales Market Share by Country (2017-2022)
Table 21. North America Hepatitis B Immune Globulin Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Hepatitis B Immune Globulin Revenue Market Share by Country (2017-2022)
Table 23. Europe Hepatitis B Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 24. Europe Hepatitis B Immune Globulin Sales Market Share by Country (2017-2022)
Table 25. Europe Hepatitis B Immune Globulin Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Hepatitis B Immune Globulin Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Hepatitis B Immune Globulin Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Hepatitis B Immune Globulin Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Hepatitis B Immune Globulin Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Hepatitis B Immune Globulin Revenue Market Share by Region (2017-2022)
Table 31. Latin America Hepatitis B Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Hepatitis B Immune Globulin Sales Market Share by Country (2017-2022)
Table 33. Latin America Hepatitis B Immune Globulin Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Hepatitis B Immune Globulin Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Hepatitis B Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Hepatitis B Immune Globulin Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Hepatitis B Immune Globulin Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Hepatitis B Immune Globulin Revenue Market Share by Country (2017-2022)
Table 39. Global Hepatitis B Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 40. Global Hepatitis B Immune Globulin Sales Market Share by Type (2017-2022)
Table 41. Global Hepatitis B Immune Globulin Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Hepatitis B Immune Globulin Revenue Share by Type (2017-2022)
Table 43. Global Hepatitis B Immune Globulin Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Hepatitis B Immune Globulin Sales (K Units) by Application (2017-2022)
Table 45. Global Hepatitis B Immune Globulin Sales Market Share by Application (2017-2022)
Table 46. Global Hepatitis B Immune Globulin Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Hepatitis B Immune Globulin Revenue Share by Application (2017-2022)
Table 48. Global Hepatitis B Immune Globulin Price by Application (2017-2022) & (US$/Unit)
Table 49. ADMA Biologics Corporation Information
Table 50. ADMA Biologics Description and Business Overview
Table 51. ADMA Biologics Hepatitis B Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. ADMA Biologics Hepatitis B Immune Globulin Product
Table 53. ADMA Biologics Recent Developments/Updates
Table 54. Bio Products Laboratory Corporation Information
Table 55. Bio Products Laboratory Description and Business Overview
Table 56. Bio Products Laboratory Hepatitis B Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Bio Products Laboratory Hepatitis B Immune Globulin Product
Table 58. Bio Products Laboratory Recent Developments/Updates
Table 59. Grifols Corporation Information
Table 60. Grifols Description and Business Overview
Table 61. Grifols Hepatitis B Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Grifols Hepatitis B Immune Globulin Product
Table 63. Grifols Recent Developments/Updates
Table 64. Biotest AG Corporation Information
Table 65. Biotest AG Description and Business Overview
Table 66. Biotest AG Hepatitis B Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Biotest AG Hepatitis B Immune Globulin Product
Table 68. Biotest AG Recent Developments/Updates
Table 69. CSL Behring Corporation Information
Table 70. CSL Behring Description and Business Overview
Table 71. CSL Behring Hepatitis B Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. CSL Behring Hepatitis B Immune Globulin Product
Table 73. CSL Behring Recent Developments/Updates
Table 74. FFF Enterprises Corporation Information
Table 75. FFF Enterprises Description and Business Overview
Table 76. FFF Enterprises Hepatitis B Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. FFF Enterprises Hepatitis B Immune Globulin Product
Table 78. FFF Enterprises Recent Developments/Updates
Table 79. Cleveland Clinic Corporation Information
Table 80. Cleveland Clinic Description and Business Overview
Table 81. Cleveland Clinic Hepatitis B Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Cleveland Clinic Hepatitis B Immune Globulin Product
Table 83. Cleveland Clinic Recent Developments/Updates
Table 84. Production Base and Market Concentration Rate of Raw Material
Table 85. Key Suppliers of Raw Materials
Table 86. Hepatitis B Immune Globulin Distributors List
Table 87. Hepatitis B Immune Globulin Customers List
Table 88. Hepatitis B Immune Globulin Market Trends
Table 89. Hepatitis B Immune Globulin Market Drivers
Table 90. Hepatitis B Immune Globulin Market Challenges
Table 91. Hepatitis B Immune Globulin Market Restraints
Table 92. Global Hepatitis B Immune Globulin Sales Forecast by Type (2023-2028) & (K Units)
Table 93. Global Hepatitis B Immune Globulin Sales Market Share Forecast by Type (2023-2028)
Table 94. Global Hepatitis B Immune Globulin Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 95. Global Hepatitis B Immune Globulin Revenue Market Share Forecast by Type (2023-2028)
Table 96. Global Hepatitis B Immune Globulin Sales Forecast by Application (2023-2028) & (K Units)
Table 97. Global Hepatitis B Immune Globulin Sales Market Share Forecast by Application (2023-2028)
Table 98. Global Hepatitis B Immune Globulin Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 99. Global Hepatitis B Immune Globulin Revenue Market Share Forecast by Application (2023-2028)
Table 100. Global Hepatitis B Immune Globulin Sales Forecast by Region (2023-2028) & (K Units)
Table 101. Global Hepatitis B Immune Globulin Sales Market Share Forecast by Region (2023-2028)
Table 102. Global Hepatitis B Immune Globulin Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 103. Global Hepatitis B Immune Globulin Revenue Market Share Forecast by Region (2023-2028)
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatitis B Immune Globulin
Figure 2. Global Hepatitis B Immune Globulin Market Share by Type in 2021 & 2028
Figure 3. Intravenous Injection Product Picture
Figure 4. Intramuscular Injection Product Picture
Figure 5. Global Hepatitis B Immune Globulin Market Share by Application in 2021 & 2028
Figure 6. Liver Transplant Patients
Figure 7. Newborn Baby
Figure 8. Others
Figure 9. Global Hepatitis B Immune Globulin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Hepatitis B Immune Globulin Market Size (2017-2028) & (US$ Million)
Figure 11. Global Hepatitis B Immune Globulin Sales (2017-2028) & (K Units)
Figure 12. Hepatitis B Immune Globulin Sales Share by Manufacturers in 2021
Figure 13. Global Hepatitis B Immune Globulin Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Hepatitis B Immune Globulin Players: Market Share by Revenue in 2021
Figure 15. Hepatitis B Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Hepatitis B Immune Globulin Sales Market Share by Region (2017-2022)
Figure 17. Global Hepatitis B Immune Globulin Sales Market Share by Region in 2021
Figure 18. Global Hepatitis B Immune Globulin Revenue Market Share by Region (2017-2022)
Figure 19. Global Hepatitis B Immune Globulin Revenue Market Share by Region in 2021
Figure 20. United States Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Colombia Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Hepatitis B Immune Globulin Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Hepatitis B Immune Globulin by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Hepatitis B Immune Globulin
Figure 45. Manufacturing Process Analysis of Hepatitis B Immune Globulin
Figure 46. Hepatitis B Immune Globulin Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Industry Market Size
